Germany pledges new funds to tackle antibiotic resistance

Spotlight: August-October 2022

First RSV vaccine for older adults earns pivotal Phase 3 results

Repurposing medicines toolkit launched

Promising outlook for integrating young talent in pharma

Pfizer-BioNTech assemble with the Avengers in COVID booster drive

Historic moment in Alzheimer’s drug development

Pharma R&D set to increase despite energy crisis

Daiichi Sankyo in leukaemia treatment approval first

Pfizer and Delix named HBA gender parity champions

Moderna joins BIA as 500th member

GSK and Microsoft tackle Nepal disease transmission

First malaria vaccine granted WHO prequalification

Roche makes moves in PCR technology

Spoonful of technology

Spotlight: June-August 2022

Gilead fights monkeypox misinformation

French Biotech set to make waves in cell therapy evolution

Bayer in top spot for equality, diversity and inclusion

Access win for HIV patients in sub-Saharan Africa